Proteomics differentiate between thyroid-associated orbitopathy and dry eye syndrome

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 4, 2015, Pages 2649-2656

  Matheis, Nina ^a   Grus, Franz H ^a   Breitenfeld, Matthias ^a   Knych, Ivo ^a   Funke, Sebastian ^a   Pitz, Susanne ^a   Ponto, Katharina A ^a   Pfeiffer, Norbert ^a   Kahaly, George J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Antibody microarrays; Dry eye syndrome; Proteomics; Tear fluid; Thyroid associated orbitopathy

Indexed keywords

BRG1 PROTEIN; CALGRANULIN A; GALECTIN; HEAT SHOCK PROTEIN 27; LIPOCORTIN 1; PROLINE RICH PROTEIN; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRY EYE; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFLAMMATION; LACRIMAL FLUID; LACRIMAL FLUID LEVEL; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; SMOKING; TEAR FILM; CHEMISTRY; GRAVES OPHTHALMOPATHY; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DRY EYE SYNDROMES; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEARS; YOUNG ADULT;

EID: 84939603705     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16699     Document Type: Article

References (33)

1. Bartalena L, Fatourechi V. Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest. 2014;37: 691–700.
2. Chang TC, Huang KM, Chang TJ, Lin SL. Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves’ disease. Clin Endocrinol (Oxf). 1990; 32:551–558.
3. Eckstein AK, Finkenrath A, Heiligenhaus A, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHRspecific autoantibodies. Acta Ophthalmol Scand. 2004;82: 291–297.
4. Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Copenh). 1983;61:108–116.
5. Matheis N, Okrojek R, Grus FH, Kahaly GJ. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid. 2012;22: 1039–1045.
6. Khalil HA, De Keizer RJ, Bodelier VM, Kijlstra A. Secretory IgA and lysozyme in tears of patients with Graves’ ophthalmopathy. Doc Ophthalmol. 1989;72:329–334.
7. Baker GR, Morton M, Rajapaska RS, et al. Altered tear composition in smokers and patients with graves ophthalmopathy. Arch Ophthalmol. 2006;124:1451–1456.
8. Achtsidis V, Tentolouris N, Theodoropoulou S, et al. Dry eye in Graves ophthalmopathy: correlation with corneal hypoesthesia. Eur J Ophthalmol. 2013;23:473–479.
9. Ponto KA, Hommel G, Pitz S, Elflein H, Pfeiffer N, Kahaly GJ. Quality of life in a German graves orbitopathy population. Am J Ophthalmol. 2011;152:483–490, e481.
10. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:179–193.
11. Boehm N, Funke S, Wiegand M, Wehrwein N, Pfeiffer N, Grus FH. Alterations in the tear proteome of dry eye patients–a matter of the clinical phenotype. Invest Ophthalmol Vis Sci. 2013;54:2385–2392.
12. Funke S, Azimi D, Wolters D, Grus FH, Pfeiffer N. Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RPCapillary- HPLC-MALDI TOF/TOF MS approach. J Proteomics. 2012;75:3177–3190.
13. McArthur C, Wang Y, Veno P, Zhang J, Fiorella R. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha. Arch Oral Biol. 2002;47:443–448.
14. Kahaly GJ, Bang H, Berg W, Dittmar M. Alpha-fodrin as a putative autoantigen in Graves’ ophthalmopathy. Clin Exp Immunol. 2005;140:166–172.
15. Okrojek R, Grus FH, Matheis N, Kahaly GJ. Proteomics in autoimmune thyroid eye disease. Horm Metab Res. 2009;41: 465–470.
16. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008; 158:273–285.
17. Bohm D, Keller K, Pieter J, et al. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol Rep. 2012;28:429–438.
18. Ozyildirim AM, Wistow GJ, Gao J, et al. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Invest Ophthalmol Vis Sci. 2005;46:1572–1580.
19. Dickinson DP, Thiesse M. A major human lacrimal gland mRNA encodes a new proline-rich protein family member. Invest Ophthalmol Vis Sci. 1995;36:2020–2031.
20. Perumal N, Funke S, Pfeiffer N, Grus FH. Characterization of lacrimal proline-rich protein 4 (PRR4) in human tear proteome. Proteomics. 2014;14:1698–1709.
21. Barrett AJ, Fritz H, Grubb A, et al. Nomenclature and classification of the proteins homologous with the cysteineproteinase inhibitor chicken cystatin. Biochem J. 1986;236:312.
22. Magister S, Kos J. Cystatins in immune system. J Cancer. 2013; 4:45–56.
23. D’Acquisto F, Merghani A, Lecona E, et al. Annexin-1 modulates T-cell activation and differentiation. Blood. 2007; 109:1095–1102.
24. Turcu AF, Kumar S, Neumann S, et al. A small molecule antagonist inhibits thyrotropin receptor antibody-inducedorbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy. J Clin Endocrinol Metab. 2013;98: 2153–2159.
25. van Zeijl CJ, Fliers E, van Koppen CJ, et al. Thyrotropin receptor-stimulating Graves’ disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves’ ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid. 2011;21:169–176.
26. van Zeijl CJ, Fliers E, van Koppen CJ, et al. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves’ disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves’ ophthalmopathy patients. Thyroid. 2010;20:535–544.
27. Hansen C, Rouhi R, Forster G, Kahaly GJ. Increased sulfatation of orbital glycosaminoglycans in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 1999;84:1409–1413.
28. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45: 4293–4301.
29. Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186–193.
30. El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009;50:3802–3807.
31. Gurdal C, Genc I, Sarac O, Gonul I, Takmaz T, Can I. Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression. Curr Eye Res. 2010;35:771–777.
32. Jiang LH, Wei RL. Analysis of Graves’ ophthalmopathy patients’ tear protein spectrum. Chin Med J (Engl). 2013;126:4493–4498.
33. Cheng KC, Huang HH, Hung CT, et al. Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2013;251: 2777–2787.